SMAD4 is an important tumor suppressor gene that is found to be inactivated in approximately 50% of pancreatic cancers and has been associated with a more aggressive clinical course [5, 10, 60, 61]. This evidence concerns the gene SMAD4 and pancreatic neoplasm.